文摘
A nine-step convergent process was developed for the synthesisof ABT-472, a benzimidazole PARP inhibitor. The identity andorigin of several impurities were determined, and the processwas modified to reduce or eliminate these impurities. A numberof safety and control issues were investigated. The originalsynthesis was shortened to 9 steps and streamlined whilemaintaining a convergent strategy. A stable salt was selected,and control of the API solid form was established. The processwas successfully scaled up to provide 8.5 kg of final product of>99% purity in 33% yield over 9 steps.